ZYRTEC®
Children’s ZYRTEC® delivers effective, 24-hour allergy relief with convenient once-daily dosing and kid-friendly forms and flavors. For ages 2+.
Recommend effective relief for kids’ worst allergy symptoms: sneezing; runny nose; itchy, watery eyes; and itchy throat or nose.
-
Dosing for Children’s ZYRTEC®
-
Children’s ZYRTEC® Allergy Syrup Dosage
Effective allergy relief in a sugar-free, dye-free syrup formulation in kid-friendly grape and bubble gum flavors
Active ingredient: Cetirizine HCl 5 mg (in each mL) Age Dosage 2-5 years 2.5 mL once daily; if needed, dose can be increased to a maximum of 5 mL once daily or 2.5 mL every 12 hours. Do not give more than 5 mL in 24 hours 6 years and over 5 mL or 10 mL once daily depending on severity of symptoms. Do not take more than 10 mL in 24 hours Under 2 years Ask a doctor mL = milliliter.
Children’s ZYRTEC® Dissolve Tabs Dosage
Melt-away tablets for 24-hour relief from kids’ indoor and outdoor allergy symptoms
Active ingredient: Cetirizine HCl 10 mg (in each tablet) Directions: Tablet melts in mouth. Can be taken with or without water. Age Dosage 6 years and over One 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours Under 2 years Ask a doctor mg = milligram.
-
-
Pediatric Clinical Data
-
EFFICACY DATA
Children’s ZYRTEC® makes a significant impact on allergy symptoms1*†
Powerful symptom response seen in pediatric patients with seasonal allergic rhinitis (SAR)1
Efficacy in ages 2 to 6: Children’s ZYRTEC® 5 mg
66% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks1
Efficacy in ages 6 to 11: Children’s ZYRTEC® 10 mg
Studies show 37% and 19% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks1
*Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.
†Randomized, placebo-controlled studies of children aged 6 to 11 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.
‡Significant vs placebo.
§ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.
||ZYRTEC® 10 mg vs placebo ratio at ≥50% reduction is 1.88-fold in Study 1 and 1.42-fold in Study 2.CONSISTENCY DATA
ZYRTEC® provides proven, consistent symptom relief
Children’s symptoms improved consistently over a 2-week period*
Reduction from baseline in total symptom severity complex (TSSC)2†
- 37% and 40% reduction observed after 2 weeks of treatment in the 10-mg group
- 63% and 40% reduction observed after 2 weeks of treatment in the 5-mg group
*All studies are multicenter, randomized, placebo-controlled, double-blind in children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).
†Adjusted mean change relative to baseline.
TOLERABILITY DATA
ZYRTEC® is generally well tolerated by children1
In studies of children ages 6 to 11 years:
- 4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)1
- ≤ 1% of ZYRTEC® patients discontinued due to somnolence1
References: 1. Data on file. Johnson & Johnson Consumer Inc., McNeil Consumer Health Division. 2. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.
-
Want to explore Children’s ZYRTEC® products for your pediatric patients?
Effective relief when kids need it most
When their allergies act up, recommend BENADRYL®
Monthly Pediatric BundleBox
Discover what’s inside
All Fields required, unless otherwise indicated
Will be used as your user name
By submitting your information above, you agree that the information you provide will be governed by our site's Privacy Policy.